Russell Investments Group, Ltd. Solid Biosciences Inc. Transaction History

Russell Investments Group, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 05, 2022	BUY	$0.74 - $1.79 $20,923 - $50,612	28,275 New	28,275 $33,000
Q3 2021 Nov 08, 2021	SELL	$2.38 - $3.77 $181,467 - $287,451	-76,247 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$5.37 - $10.72 $52,889 - $105,581	-9,849 Reduced 11.44%	76,247 $421,000
Q4 2020 Feb 08, 2021	BUY	$3.08 - $7.79 $265,175 - $670,687	86,096 New	86,096 $651,000
Q3 2020 Nov 09, 2020	SELL	$2.02 - $3.08 $95,899 - $146,223	-47,475 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$2.1 - $3.42 $99,697 - $162,364	47,475 New	47,475 $139,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $53.2M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Russell Investments Group, Ltd. with notifications on news.